You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-ABL1 (ABL1) Antibodies

Full name:
anti-C-Abl Oncogene 1, Non-Receptor tyrosine Kinase Antibodies (ABL1)
On www.antibodies-online.com are 613 C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1) Antibodies from 26 different suppliers available. Additionally we are shipping ABL1 Proteins (26) and ABL1 Kits (12) and many more products for this protein. A total of 708 ABL1 products are currently listed.
Synonyms:
Abl, ABL1, ABLL, AI325092, bcr/abl, c-Abl, CABL, cb272, E430008G22Rik, JTK7, MTP, p150, v-abl
list all antibodies Gene Name GeneID UniProt
ABL1 25 P00519
ABL1 11350 P00520
ABL1 311860  

Show all species

Show all synonyms

Most Popular Reactivities for anti-ABL1 (ABL1) Antibodies

Select your species and application

anti-Human ABL1 Antibodies:

anti-Mouse (Murine) ABL1 Antibodies:

anti-Rat (Rattus) ABL1 Antibodies:

All available anti-ABL1 Antibodies

Go to our pre-filtered search.

Top referenced anti-ABL1 Antibodies

  1. Human Polyclonal ABL1 Primary Antibody for DB, IHC (p) - ABIN389501 : Barnes, McIntosh, Whetton, Daley, Bentley, Baldwin: Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation. in Oncogene 2005 (PubMed)
    Show all 6 references for ABIN389501

  2. Human Polyclonal ABL1 Primary Antibody for IF, IHC (p) - ABIN389502 : Kim, Cho, Yoon, Park, Kim, Lee, Chun, Kim, Lee et al.: Interpretation of submicroscopic deletions of the BCR or ABL gene should not depend on extra signal-FISH: problems in interpretation of submicroscopic deletion of the BCR or ABL gene with extra ... in Genes, chromosomes & cancer 2005 (PubMed)
    Show all 5 references for ABIN389502

  3. Human Polyclonal ABL1 Primary Antibody for DB, IF - ABIN389865 : Aichberger, Mayerhofer, Krauth, Skvara, Florian, Sonneck, Akgul, Derdak, Pickl, Wacheck, Selzer, Monia, Moriggl, Valent, Sillaber: Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides. in Blood 2005 (PubMed)
    Show all 5 references for ABIN389865

  4. Human Polyclonal ABL1 Primary Antibody for WB - ABIN389507 : Cao, Leng, Liu, Yi, Li, Kufe: Catalase is regulated by ubiquitination and proteosomal degradation. Role of the c-Abl and Arg tyrosine kinases. in Biochemistry 2003 (PubMed)
    Show all 4 references for ABIN389507

  5. Human Polyclonal ABL1 Primary Antibody for ELISA, WB - ABIN1532033 : Fainstein, Einat, Gokkel, Marcelle, Croce, Gale, Canaani: Nucleotide sequence analysis of human abl and bcr-abl cDNAs. in Oncogene 1990 (PubMed)
    Show all 3 references for ABIN1532033

  6. Human Polyclonal ABL1 Primary Antibody for IF, ELISA - ABIN1531424 : Chissoe, Bodenteich, Wang, Wang, Burian, Clifton, Crabtree, Freeman, Iyer, Jian: Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. in Genomics 1995 (PubMed)
    Show all 3 references for ABIN1531424

  7. Mouse (Murine) Polyclonal ABL1 Primary Antibody for IHC (p), WB - ABIN657828 : Ko, Lee, Shin, Karuppagounder, Gadad, Koleske, Pletnikova, Troncoso, Dawson, Dawson: Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. in Proceedings of the National Academy of Sciences of the United States of America 2010 (PubMed)
    Show all 2 references for ABIN657828

  8. Human Polyclonal ABL1 Primary Antibody for WB - ABIN392079 : Donaldson, Gish, Pawson, Kay, Forman-Kay: Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide. in Proceedings of the National Academy of Sciences of the United States of America 2002 (PubMed)

  9. Human Polyclonal ABL1 Primary Antibody for IF, IHC - ABIN1531765 : Krapivinsky, Medina, Krapivinsky, Gapon, Clapham: SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation. in Neuron 2004 (PubMed)

More Antibodies against ABL1 Interaction Partners

Human C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1) interaction partners

  1. though our data support the previous findings that co-expression of BCR-ABL transcripts is due to the occurrence of exonic and intronic polymorphisms in the BCR gene, it also shows that the intronic polymorphism can arise without the linked exonic polymorphism. The occurrence of ABL kinase domain mutation is less frequent in Indian population.

  2. In silico three-dimensional modeling of apoptin, molecular docking experiments between apoptin model and the known structure of Bcr-Abl, and the 3D structures of SH2 domains of CrkL (show CRKL Antibodies) and Bcr-Abl, were performed.

  3. The present study screened for the presence of bcr-abl transcripts in the blood of a group of healthy individuals.

  4. inhibition of c-Abl minimizes receptor recycling pathways and results in chaperone-dependent trafficking of the TfR1 (show TFRC Antibodies) to the lysosome for degradation.

  5. MTP Gene Variants are associated with Homozygous Familial Hypercholesterolemia.

  6. Data indicate that the biosensor showed excellent analytical performance for the detection of the BCR/ABL oncogene in clinical samples of patients with leukemia.

  7. In this review, we examine the evidence to illuminate the molecular mechanism of ABL1 in the progression of gastric cancer (GC) patients with depression and identify out new and effective methods for the initial and longterm treatment of GC.

  8. Studies indicate that the prognosis of BCR-ABL-positive acute myeloid leukemia (show BCL11A Antibodies) (BCR-ABL+ AML (show RUNX1 Antibodies)) seems to depend on the cytogenetic and/or molecular background rather than on BCR-ABL itself.

  9. Results indicate that eIF4B (show EIF4B Antibodies) integrates the signals from Pim (show PIM1 Antibodies) and PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies)/mTOR (show FRAP1 Antibodies) pathways in Abl-expressing leukemic cells.

  10. The notion that regular and close monitoring of MSI2 (show MSI2 Antibodies) mRNA levels in chronic myeloid leukemia (show BCL11A Antibodies) patients might identify patients at risk of progressing to blast crisis was not supported by this study; an increase in MSI2 (show MSI2 Antibodies) transcripts does not precede an increase in BCR (show BCR Antibodies)-ABL1 mRNA levels.

Mouse (Murine) C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1) interaction partners

  1. p38a (show MAPK14 Antibodies) as a major substrate of c-Abl both in vitro and in vivo and c-Abl-mediated phosphorylation is critical for the dimerization of p38a (show MAPK14 Antibodies).

  2. Our data show that: i) HDAC2 (show HDAC2 Antibodies) levels and activity are increased in NPC (show NPC1 Antibodies) neuronal models and in Npc1 (show NPC1 Antibodies)(-/-) mice; ii) inhibition of c-Abl or c-Abl deficiency prevents the increase of HDAC2 (show HDAC2 Antibodies) protein levels and activity in NPC (show NPC1 Antibodies) neuronal models

  3. The resistance in BCR (show BCR Antibodies)-ABL1 cells resulted either from the Y253H mutation in the BCR (show BCR Antibodies)-ABL1 gene or incubation in increasing concentrations of imatinib.

  4. These results reveal a new pathway in the DNA damage response wherein ABL-dependent tyrosine phosphorylation of DGCR8 (show DGCR8 Antibodies) stimulates the processing of selective primary miRNAs.

  5. These findings connect the EphB signaling pathway to the regulation of intestinal adenoma initiation via Abl kinase.

  6. overexpression of Id2 in primary alveolar epithelial cells promotes proliferation by inhibiting a retinoblastoma protein/c-Abl interaction leading to greater c-Abl activity.

  7. The study demonstrates a previously unrecognized mechanism that controls insulin (show INS Antibodies) expression through c-Abl-regulated NKx2.2 (show Nkx2-2 Antibodies) and GLUT2 (show SLC2A2 Antibodies).

  8. Oocyte-specific inactivation of Omcg1 leads to DNA damage and c-Abl/TAp63-dependent oocyte death associated with dramatic remodeling of ovarian somatic cells.

  9. LPS-induced paxillin phosphorylation at Y31 and Y118 was mediated by c-Abl tyrosine kinase

  10. c-Abl modulates tumor cell sensitivity to antibody-dependent cellular cytotoxicity.

Caenorhabditis elegans (C. elegans) C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1) interaction partners

  1. By screening candidate genes involved in Eph (show EPHA1 Antibodies) signaling, we find that the Eph (show EPHA1 Antibodies) kinase-independent pathway involves the ABL-1 nonreceptor tyrosine kinase (show TYRO3 Antibodies) and possibly the phosphatidylinositol 3-kinase pathway

  2. The trade-off in immunological susceptibility in C. elegans is further mediated by the reciprocal activity of lys (show LYZ Antibodies)-7 and the tyrosine kinase abl-1.

  3. oxidative, osmotic, heat shock and starvation stresses induce germ cell apoptosis through a p53 (show TP53 Antibodies) and EGL-1 independent pathway; the MAPK (show MAPK1 Antibodies) kinases MEK-1 (show MAP2K1 Antibodies) and SEK-1 (show MAP2K4 Antibodies), and the p53 (show TP53 Antibodies) antagonist protein ABL-1, are essential for stress-induced germ cell apoptosis

  4. findings demonstrate that ABL-1, the C. elegans homolog of the mammalian c-Abl nonreceptor tyrosine kinase (show TYRO3 Antibodies) ABL1, is required for Shigella flexneri pathogenesis in nematodes

ABL1 Antigen Profile

Antigen Summary

MTP encodes the large subunit of the heterodimeric microsomal triglyceride transfer protein. Protein disulfide isomerase (PDI) completes the heterodimeric microsomal triglyceride transfer protein, which has been shown to play a central role in lipoprotein assembly. Mutations in MTP can cause abetalipoproteinemia.

Alternative names and synonyms associated with ABL1

  • c-abl oncogene 1, receptor tyrosine kinase (ABL1) antibody
  • c-abl oncogene 1, non-receptor tyrosine kinase (ABL1) antibody
  • v-abl Abelson murine leukemia viral oncogene homolog 2 (ABL2) antibody
  • v-abl Abelson murine leukemia viral oncogene homolog 2 (abl2) antibody
  • c-abl oncogene 1, non-receptor tyrosine kinase (Abl1) antibody
  • microsomal triglyceride transfer protein (MTTP) antibody
  • Protein ABL-1 (abl-1) antibody
  • Abl antibody
  • ABL1 antibody
  • ABLL antibody
  • AI325092 antibody
  • bcr/abl antibody
  • c-Abl antibody
  • CABL antibody
  • cb272 antibody
  • E430008G22Rik antibody
  • JTK7 antibody
  • MTP antibody
  • p150 antibody
  • v-abl antibody

Protein level used designations for ABL1

c-abl oncogene 1, receptor tyrosine kinase , v-abl Abelson murine leukemia viral oncogene homolog 1 , Abelson murine leukemia viral (v-abl) oncogene homolog 1 , v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) , tyrosine kinase ABL , Abelson murine leukemia viral (v-abl) oncogene homolog 2 , Abelson tyrosine-protein kinase 2 , arg, Abelson-related , tyrosine-protein kinase ABL2 , v-abl Abelson murine leukemia viral oncogene homolog 2 , arg tyrosine kinase , tyrosine-protein kinase ABL2-like , Abelson tyrosine-protein kinase 1 , bcr/c-abl oncogene protein , proto-oncogene c-Abl , proto-oncogene tyrosine-protein kinase ABL1 , tyrosine-protein kinase ABL1 , Abelson murine leukemia oncogene , abelson murine leukemia viral oncogene homolog 1 , p150 , v-abl Abelson murine leukemia oncogene 1 , v-abl Abelson murine leukemia viral oncogene 1 , microsomal triglyceride transfer protein (large polypeptide, 88kDa) , microsomal triglyceride transfer protein large subunit

GENE ID SPECIES
280970 Bos taurus
417181 Gallus gallus
464802 Pan troglodytes
491292 Canis lupus familiaris
395410 Gallus gallus
457552 Pan troglodytes
511845 Bos taurus
570636 Danio rerio
717037 Macaca mulatta
100348328 Oryctolagus cuniculus
100463896 Ailuropoda melanoleuca
100543723 Meleagris gallopavo
100588798 Nomascus leucogenys
25 Homo sapiens
540876 Bos taurus
11350 Mus musculus
311860 Rattus norvegicus
4547 Homo sapiens
181261 Caenorhabditis elegans
Selected quality suppliers for anti-ABL1 (ABL1) Antibodies
Did you look for something else?